IPM research programs will enable scientists, health care providers, educators, statistical geneticists, and policy experts can work together as interdisciplinary, interdepartmental research groups. Our strategic disease focus areas include:

• autoimmune disorders
• fibrotic and inflammatory disorders
• neuropsychiatric and neurodegenerative disorders
• cardiovascular disorders
• obesity/diabetes/metabolic disorders
• cancer
• asthma and hypersensitivity disorders

All of our programs are designed to create new research opportunities and synergies in translational genomics of common, complex disorders and pharmacogenomics by:

• standardizing clinical phenotyping methods
• developing common data elements, shared databases and patient registries and appropriate control populations
• supporting genotype-phenotype association research
• validating molecular and genetic markers in clinical care settings at Mount Sinai
• providing provider and public education